Trials / Unknown
UnknownNCT01488591
Biomarker Research for Personalized Medicine
Biomarker Research for Personalized Medicine in Blood Cancer Patient
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Inje University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this study : 1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment 2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Conditions
Timeline
- Start date
- 2009-04-01
- First posted
- 2011-12-08
- Last updated
- 2013-05-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01488591. Inclusion in this directory is not an endorsement.